734 resultados para Childhood immunisation
Resumo:
Infectious Diseases - Childhood Immunisation
Resumo:
This booklet summarises the childhood immunisation programme and provides guidance for professionals administering vaccines.
Resumo:
This booklet summarises the childhood immunisation programme and provides guidance for professionals adminstering vaccines.
Resumo:
This booklet contains the facts about the vaccine against diphtheria, tetanus, whooping cough (pertussis) and polio, and the MMR booster given to children before they start school
Resumo:
This poster, for display in treatment rooms, summarises the childhood immunisation programme for professionals, including the brand names of vaccines given.
Resumo:
Background Cost-effectiveness studies have been increasingly part of decision processes for incorporating new vaccines into the Brazilian National Immunisation Program. This study aimed to evaluate the cost-effectiveness of 10-valent pneumococcal conjugate vaccine (PCV10) in the universal childhood immunisation programme in Brazil. Methods A decision-tree analytical model based on the ProVac Initiative pneumococcus model was used, following 25 successive cohorts from birth until 5 years of age. Two strategies were compared: (1) status quo and (2) universal childhood immunisation programme with PCV10. Epidemiological and cost estimates for pneumococcal disease were based on National Health Information Systems and literature. A 'top-down' costing approach was employed. Costs are reported in 2004 Brazilian reals. Costs and benefits were discounted at 3%. Results 25 years after implementing the PCV10 immunisation programme, 10 226 deaths, 360 657 disability-adjusted life years (DALYs), 433 808 hospitalisations and 5 117 109 outpatient visits would be avoided. The cost of the immunisation programme would be R$10 674 478 765, and the expected savings on direct medical costs and family costs would be R$1 036 958 639 and R$209 919 404, respectively. This resulted in an incremental cost-effectiveness ratio of R$778 145/death avoided and R$22 066/DALY avoided from the society perspective. Conclusion The PCV10 universal infant immunisation programme is a cost-effective intervention (1-3 GDP per capita/DALY avoided). Owing to the uncertain burden of disease data, as well as unclear long-term vaccine effects, surveillance systems to monitor the long-term effects of this programme will be essential.
Resumo:
This booklet provides advice on the BCG (Bacillus Calmette-Guerin) vaccination which offers protection against tuberculosis (TB)
Resumo:
This booklet provides the facts about the MMR vaccine against measles, mumps and rubella
Resumo:
This booklet explains about the routine immunisations that are offered to all young people before they leave school
Resumo:
This booklet provides information on the routine immunisations that are given to babies to protect them from serious childhood diseases.
Resumo:
This booklet provides information on the routine immunisations that are given to babies up to a year oldto protect them from serious childhood diseases.
Resumo:
This booklet provides information on the routine immunisations that are given to babies up to year old to protect them from serious childhood diseases.Please note, the following translations are based on last year's leaflet and do not yet include the new information. Translations of the latest leaflet will follow.
Resumo:
This booklet provides information on the routine immunisations that are given to babies up to year old to protect them from serious childhood diseases. It describes the DtaP/IPV/Hib, pneumococcal and MenC vaccines and now includes information on the rotavirus vaccine given to babies at two and three months old from July 2013.(A new version will be available from summer 2015)
Resumo:
Routine childhood immunisations from September 2015